Very Modifiable |
Difficulty navigating the system when reporting |
48.5 |
42.7 |
6.8 |
1.0 |
1.0 |
114.82; <.001 |
|
Difficulty downloading and installing the app versions of the system |
46.6 |
41.7 |
9.7 |
1.0 |
1.0 |
103.55; <.001 |
Lack of awareness of existence of the electronic reporting system |
46.6 |
42.7 |
2.9 |
6.8 |
1.0 |
105.69; <.001 |
Lack of Internet access provision at the workplace |
44.7 |
37.9 |
11.7 |
4.9 |
1.0 |
81.81; <.001 |
Difficulty accessing the system online |
44.7 |
38.8 |
8.7 |
5.8 |
1.9 |
83.26; <.001 |
Extra cost of electronic reporting (Internet data costs) |
39.8 |
35.0 |
17.5 |
6.8 |
1.0 |
59.67; <.001 |
Lack of a culture of pharmacovigilance reporting |
36.9 |
38.8 |
16.5 |
6.8 |
1.0 |
61.22; <.001 |
Existence of a paper-based system as an alternative for reporting |
41.7 |
35.9 |
15.5 |
1.9 |
4.9 |
67.05; <.001 |
Limited access to computers at the workplace |
47.6 |
24.3 |
13.6 |
14.6 |
0.0 |
30.86; <.001 |
Lack of support/incentives from management to use the system for reporting |
34.0 |
38.8 |
20.4 |
2.9 |
3.9 |
56.76; <.001 |
Unreliable Internet coverage at the workplace |
33.0 |
38.8 |
14.6 |
11.7 |
1.9 |
48.89; <.001 |
Extra time involved in using the system to submit the reports |
27.2 |
45.6 |
18.4 |
2.9 |
5.8 |
62.00; <.001 |
Lack of an option for anonymous reporting in the system |
34.0 |
38.8 |
13.6 |
7.8 |
5.8 |
48.51; <.001 |
No practical benefits of using the electronic system |
28.2 |
40.8 |
19.4 |
9.7 |
1.9 |
47.92; <.001 |
Unreliable electricity at the workplace |
28.2 |
36.9 |
17.5 |
12.6 |
4.9 |
33.07; <.001 |
Least Modifiable |
Dislike of computer technology |
32.0 |
32.0 |
21.4 |
8.7 |
5.8 |
31.90; <.001 |